Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GBP510 Vaccine in Healthy Adults
NCT04750343Phase 2Unknown
- Sponsor
- SK bioscience
- Start
- Feb 2021
- Primary completion
- Jul 2021
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GBP510 + AS03 in coronavirus disease 2019 (COVID-19), sponsored by SK bioscience. Status: unknown.
02
Drugs
GBP510 + AS03
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04750343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750343.